Monkey ~3-fold and rat (MTD) ~2-fold human systemic exposure at recommended dose
“The systematic exposure to AGS-22M6E in cynomolgus monkeys was ~3-fold the human systemic exposure at the recommended clinical dose. In rats, at the maximum tolerated dose (MTD), the systematic exposure was also ~2-fold the human systemic exposure at the recommended clinical dose.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
NOAEL / key findings
Monkey HNSTD/MTD 3 mg/kg, rat MTD 5 mg/kg; skin, injection site, bone marrow, liver, eye, male reproductive organs
“In the 4-week monkey study (# 20005664), AGS-22M6E systemic exposure at 3 mg/kg (MTD/HNSTD) was 2450 µg.hr/mL (Day 1) and 903 µg.hr/mL (Day 22).”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗